{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-25-000052","form_type":"8-K/A","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2025-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.878001+00:00","generated_at":"2026-05-24T11:27:11.145628+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NeoGenomics promotes Warren Stone to President & COO; Melody Harris to depart","bullets":["Warren Stone promoted to President & COO effective April 1, 2025; previously CCO.","Stone's base salary increased to $650k, target bonus 70%, equity target $3M, plus incremental $1M equity.","Melody Harris to depart end of May 2025; her role as COO and President, Oncology Data Solutions eliminated.","Beth Eastland, SVP Enterprise Sales, to support Stone and assume day-to-day enterprise sales functions."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-25-000052","json":"https://secwatch.observer/filing/0001077183-25-000052.json","markdown":"https://secwatch.observer/filing/0001077183-25-000052.md","text":"https://secwatch.observer/filing/0001077183-25-000052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000052/0001077183-25-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000052/neo-20250318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T11:27:11.145628+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2522f9213e","claim":"Warren Stone changed role as President & Chief Operating Officer at NEOGENOMICS INC.","evidence_excerpt":"On March 18, 2025, NeoGenomics, Inc. (the \"Company\") announced the promotion of Warren Stone, the Company's current Chief Commercial Officer, to the position of President & Chief Operating Officer, effective April 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000052/0001077183-25-000052-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"President & Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"68b8fabf65","claim":"Melody Harris departed as Chief Operations Officer and President, Oncology Data Solutions at NEOGENOMICS INC.","evidence_excerpt":"Additionally, on March 18, 2025, the Company announced that the Chief Operations Officer and President, Oncology Data Solutions position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer and President, Oncology Data Solutions will no longer hold such role effective April 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000052/0001077183-25-000052-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"position eliminated"},{"label":"Role","value":"Chief Operations Officer and President, Oncology Data Solutions"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}